Qiagen NV Stock Deutsche Boerse AG
Stocks
NL0000240000
Biotechnology & Medical Research
|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 08-12 | Qiagen N.V. : DZ Bank reiterates its Buy rating | ZD |
| 08-10 | Qiagen Wins FDA Clearance for Bloodstream Infection Test | DJ |
| Market Cap | 9.2B 7.88B 7.35B 6.75B 12.68B 881B 12.93B 87.21B 34B 441B 34.55B 33.8B 1,461B | P/E 2026 * |
21.3x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 9.79B 8.38B 7.82B 7.18B 13.48B 937B 13.75B 92.77B 36.16B 469B 36.76B 35.96B 1,554B | EV / Sales 2026 * |
4.57x | EV / Sales 2027 * | 4.18x |
| Free-Float |
99.37% | Yield 2026 * |
0.58% | Yield 2027 * | 0.72% |
Last Transcript: Qiagen NV
| Manager | Title | Age | Since |
|---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 61 | 2019-10-06 |
Roland Sackers
DFI | Director of Finance/CFO | 58 | 2003-12-31 |
Antonio Santos
COO | Chief Operating Officer | - | 2022-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 77 | 2011-05-31 | |
Toralf Haag
BRD | Director/Board Member | 60 | 2021-01-07 |
Eva Pisa
BRD | Director/Board Member | 72 | 2022-06-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | +2.27% | +2.38% | +24.66% | 50.5B | |
| -1.84% | +4.46% | +483.52% | +606.39% | 46.01B | |
| -1.22% | +4.55% | +20.32% | +89.78% | 42.85B | |
| +4.00% | +7.11% | +34.70% | +20.68% | 41.03B | |
| 0.00% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +1.66% | +6.45% | +33.01% | +151.84% | 16.98B | |
| -1.54% | +4.14% | - | - | 17.05B | |
| +3.06% | +3.88% | +5.81% | +35.45% | 14.3B | |
| +2.77% | +5.16% | +85.35% | +47.22% | 13.84B | |
| Average | +0.94% | +2.01% | +85.37% | +128.00% | 30.51B | |
| Weighted average by Cap. | +0.69% | +2.37% | +105.07% | +151.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.14B 1.83B 1.71B 1.57B 2.95B 205B 3.01B 20.31B 7.92B 103B 8.05B 7.87B 340B | 2.25B 1.93B 1.8B 1.65B 3.1B 215B 3.16B 21.34B 8.32B 108B 8.46B 8.27B 357B |
| Net income | 399M 341M 319M 292M 549M 38.16B 560M 3.78B 1.47B 19.13B 1.5B 1.47B 63.32B | 479M 410M 383M 351M 660M 45.82B 672M 4.54B 1.77B 22.96B 1.8B 1.76B 76.02B |
| Net Debt | 587M 502M 469M 430M 808M 56.14B 824M 5.56B 2.17B 28.14B 2.2B 2.16B 93.15B | 214M 183M 171M 157M 295M 20.48B 301M 2.03B 791M 10.26B 804M 786M 33.98B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
